PREMARKET REVIEW COMPLIANCE PERIODS
For newly deemed products that are on the market on the effective date of the final rule and were not on the market on February 15, 2007:
August 8, 2016 to August 8, 2017
Manufacturer may submit an SE exemption request (however, FDA can “refuse-to-accept” an incomplete SE exemption request, and then it is not considered submitted).
August 8, 2016 to February 8, 2018
Manufacturer may submit an SE report (however, FDA can “refuse-to-accept” an incomplete SE report, and then it is not considered submitted).
August 8, 2016 to August 8, 2018
Manufacturer may submit a PMTA (however, FDA can “refuse-to-accept” an incomplete PMTA, and then it is not considered submitted).
If the manufacturer submits and FDA accepts one of the submissions by the deadline stated above, FDA will not take enforcement action against that product for one year. However, at the end of that period, even if FDA has not completed its review, the product will be subject to enforcement action unless FDA determines that “substantial progress” is being made towards completion.
Blending changes to address the natural variation of tobacco in order to maintain a consistent product do not require preauthorization, but the ingredients must be listed. Blending changes intended to alter the chemical or perception of the product (e.g., nicotine level, pH, smoothness, or harshness, etc.), including seasonal and limited release products, do require premarket authorization.